NCT02692105View on ClinicalTrials.gov

Comparison of HDR vs. LDR Brachytherapy as Monotherapy for Intermediate Risk Prostate Cancer

PHASE3Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 31, 2016

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2026

Conditions
Prostate Cancer
Interventions
RADIATION

Low dose rate prostate brachytherapy

Permanent implantation of radioactive Iodine-125 seeds under anesthesia with ultrasound guidance

RADIATION

High Dose Rate prostate brachytherapy

Temporary implantation of radioactive material into the prostate in the form of a stepping source of Iridium 192 that travels through 16-18 needles or catheters strategically placed through the prostate

Trial Locations (1)

V1Y5L3

British Columbia Cancer Agency Center for the Southern Interior, Kelowna

All Listed Sponsors
lead

British Columbia Cancer Agency

OTHER